Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

AIMS: To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfunction (SOLVD) Treatment trial. METHODS AND RESULTS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Heart Fail
Autors principals: Lam, Phillip H., Dooley, Daniel J., Fonarow, Gregg C., Butler, Javed, Bhatt, Deepak L., Filippatos, Gerasimos S., Deedwania, Prakash, Forman, Daniel E., White, Michel, Fletcher, Ross D., Arundel, Cherinne, Blackman, Marc R., Adamopoulos, Chris, Kanonidis, Ioannis E., Aban, Inmaculada B., Patel, Kanan, Aronow, Wilbert S., Allman, Richard M., Anker, Stefan D., Pitt, Bertram, Ahmed, Ali
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500736/
https://ncbi.nlm.nih.gov/pubmed/28980368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.937
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars